ReviewJournal of medicine and life2023
Brain imaging and morphological plasticity in glioblastoma: a literature review.
Review in Journal of medicine and life, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
- Standardized brain tumor imaging protocols for clinical trials: current recommendations and tips for integration.Frontiers in radiology · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article provides a comprehensive review of the role of functional magnetic resonance imaging (fMRI) in characterizing neural plasticity in glioblastoma patients. Glioblastoma, the most common primary brain tumor, has a rapid growth rate and infiltrative nature that leads to the disorganization of the normal brain network. Neuroplasticity, still not fully understood, is the foundation for the development of brain functions during the growth and recovery of certain brain functions after a brain lesion such as a tumor, trauma, or vascular event. Functional MRI has the capacity to identify the regions that activate at rest or when performing a task. It can determine the extent to which these regions, responsible for a specific function, are impacted by a tumor and eventually after surgical excision. Likewise, it can help evaluate to which extent activation changes when recovery of function occurs. In this article, we aimed to understand the significance of fMRI in the management of glioblastoma by analyzing representative articles from the literature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.